Rizvi Sabina 4
4 · MusclePharm Corp · Filed Jul 28, 2022
Insider Transaction Report
Form 4
MusclePharm CorpMSLP
Rizvi Sabina
DirectorPresident & CFO
Transactions
- Award
Options (right to buy)
2021-12-21+1,811,000→ 1,811,000 totalExercise: $0.40From: 2022-04-01Exp: 2031-12-22→ Common stock (1,811,000 underlying)
Footnotes (1)
- [F1]Options were granted pursuant to MusclePharm Corporation's 2021 Omnibus Equity Incentive Plan and vested fully on April 1, 2022.